Medicine and Dentistry
Pyruvic Acid
100%
In Vitro
100%
Alteplase
100%
Reactive Oxygen Species
50%
Gelatinase A
30%
Reduced Nicotinamide Adenine Dinucleotide Phosphate
20%
Nicotinamide Adenine Dinucleotide Phosphate
20%
Endothelial Cell
20%
Adenosine Triphosphate
20%
Antiapoptotic
20%
Therapeutic Window
20%
Cell Viability
20%
Protein Kinase B
20%
Tissue Inhibitor of Metalloproteinase 2
20%
Side Effect
10%
Blood Brain Barrier
10%
Hypoxia
10%
Apoplexy
10%
Dichlorofluorescein
10%
Cytotoxicity
10%
Acetoacetic Acid
10%
Immunoblotting
10%
Astrocyte
10%
Calcein
10%
Fluorescein Isothiocyanate Dextran
10%
Gelatin
10%
Propidium Iodide
10%
Spectrophotometry
10%
Phosphorus
10%
Cell Junction
10%
Lipocortin 5
10%
Zymography
10%
Keyphrases
Oxygen-glucose Deprivation
100%
Recombinant Tissue Plasminogen Activator (rt-PA)
100%
Matrix metalloproteinase-2 (MMP-2)
25%
P70S6K
16%
NADP+
16%
Nicotinamide Adenine Dinucleotide Phosphate (NADPH)
16%
Anti-apoptotic
16%
Therapeutic Window
16%
TIMP-2
16%
Deoxygenation
16%
ATP Content
16%
ROS Formation
16%
Cytotoxicity
8%
Primary Astrocytes
8%
Phosphorylation
8%
Reactive Oxygen Species
8%
Cytotoxic Activity
8%
Clinical Application
8%
Immunoblot
8%
Apoptotic Pathway
8%
2′,7′-Dichlorofluorescein
8%
Diacetate
8%
Neuronal Cells
8%
HT22 Cells
8%
Cell Viability
8%
Blood-brain Barrier
8%
Calcein
8%
Annexin V/propidium Iodide
8%
Endothelial Monolayer
8%
Hypoxia-reoxygenation
8%
Spectrophotometry
8%
Cellular Viability
8%
Cellular Content
8%
Vascular Endothelial Cells
8%
Gelatin Zymography
8%
HT22
8%
Microvascular Endothelium
8%
FITC-dextran
8%
Hemorrhagic Transformation
8%
Intercellular Junctions
8%